FOLH1 and posterior cortical atrophy: Small molecule PSMA inhibitors based on a Lys-urea-Glu motif exhibit high and selective uptake by PCa cells, which has been exploited for diagnostic and therapeutic applications by coupling them to different radionuclides [3,4].